Analysts expect Unicycive Therapeutics, Inc. to report revenue of 739,301.40 for Q3 26, against a range of 696,970.48 to 781,632.32. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 781,632.32 | 794,045.99 | 16.86 M | 26.80 M | 27.55 M | 23.74 M | 133.01 M | 156.46 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 696,970.48 | 651,937.61 | 15.08 M | 25.14 M | 23.60 M | 20.70 M | 122.15 M | 143.28 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 739,301.40 | 722,991.80 | 15.97 M | 25.97 M | 25.58 M | 22.22 M | 127.58 M | 149.87 M |
Analysts expect Unicycive Therapeutics, Inc. to report earnings per share of -0.36 for Q3 26, against a range of -0.39 to -0.33. The most recent reported quarter, Q2 26, came in at -0.06, a 87.8% beat against the -0.49 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.50 | 2.50 | -0.50 | -0.52 | -0.33 | -0.32 | -0.54 | -0.06 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.38 | -0.83 | -0.59 | -0.68 | -0.50 | -0.45 | -0.43 | -0.46 | -0.33 | -0.29 | 0.10 | 0.28 | 0.16 | 0.26 | 1.61 | 2.26 | ||||||||||
| Low Estimate | -1.60 | -0.97 | -0.67 | -0.74 | -0.60 | -0.51 | -0.51 | -0.52 | -0.39 | -0.33 | 0.08 | 0.26 | 0.14 | 0.24 | 1.33 | 2.08 | ||||||||||
| Consensus Estimate | -1.49 | -0.90 | -0.63 | -0.71 | -0.55 | -0.48 | -0.47 | -0.49 | -0.36 | -0.31 | 0.09 | 0.27 | 0.15 | 0.25 | 1.47 | 2.17 |
Pull Wall Street consensus for Unicycive Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=UNCY&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "UNCY", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=UNCY&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();